Modulation of the intestinal microbiota as a means of primary and secondary prevention of cardiovascular catastrophes
Background. Cardiovascular diseases associated with dyslipidemia are the leading causes of mortality and disability of the population. The peculiarities of drug therapy of hypercholesterolemia dictate the need to take into account the individual characteristics of patients, among whom persons with c...
Saved in:
Main Author: | V. A. Akhmedov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Open Systems Publication
2023-11-01
|
Series: | Лечащий Врач |
Subjects: | |
Online Access: | https://journal.lvrach.ru/jour/article/view/1134 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness of patient-oriented intervention in primary prevention of cardiovascular diseases with statins:
Open-label randomized study
by: Elena Bochkareva, et al.
Published: (2025-06-01) -
EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ RUSSIAN NATIONAL ATHEROSCLEROSIS SOCIETY (RNAS, RUSSIA) GUIDELINES FOR THE DIAGNOSIS AND CORRECTION OF DYSLIPIDEMIA FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS (2020)
by: V. V. Kukharchuk, et al.
Published: (2020-06-01) -
Role of bile acids in atherogenesis: review
by: A. S. Safaryan
Published: (2024-11-01) -
CENTRALISED SURVEY ON THE UNDERTREATMENT OF THE HYPERCHOLESTEROLEMIA IN RUSSIA (CEPHEUS)
by: S. A. Boytsov, et al.
Published: (2013-08-01) -
LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY)
by: N. M. Akhmedzhanov, et al.
Published: (2016-05-01)